Back to stocks
KPTI

KPTI

Karyopharm Therapeutics Inc.

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
14
Partial Q3 2026
Total 13F value
$738K
Filed positions so far
New positions
6
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Strs Ohio

$662K542.5K0.00%New Position

China Universal Asset Management Co., Ltd.

$43K36.0K0.00%+44.0%

Stonex Group Inc.

$25K17.0K0.00%New Position

Td Waterhouse Canada Inc.

$5K5.7K0.00%Unchanged

Gamma Investing Llc

$1K8650.00%New Position

Owl Creek Wealth Partners Llc

$8366850.00%New Position

Sterling Capital Management Llc

$4153400.00%-3.4%

Caitong International Asset Management Co., Ltd

$3042490.00%+1678.6%

Mb, Levis & Associates, Llc

$1221000.00%Unchanged

Sbi Securities Co., Ltd.

$84690.00%+3.0%

Farther Finance Advisors, Llc

$81660.00%New Position

Activest Wealth Management

$81660.00%Unchanged

Ifp Advisors, Inc

$970.00%New Position

West Branch Capital Llc

$430.00%Unchanged

Explore